Clinical trial
Nitric Oxide to Improve Blood Flow in Sickle Cell Disease
NCT00009581 · National Institutes of Health Clinical Center (CC), NIH · Completed
Key facts
| NCT number | NCT00009581 |
|---|---|
| Title | Nitric Oxide to Improve Blood Flow in Sickle Cell Disease |
| Official title | Targeted Delivery of Nitric Oxide by Hemoglobin to Improve Regional Blood Flow in Sickle Cell Disease |
| Lead sponsor | National Institutes of Health Clinical Center (CC), NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Sickle Cell Anemia |
| Intervention type | Drug |
| Interventions | L-NMMA, Acetylcholine |
| Enrollment | 65 |
| Start date | Jan 1, 2001 |
| Completion | Jan 1, 2003 |
| First posted | Feb 2, 2001 |
| Last update posted | Mar 4, 2008 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: